Pressmeddelande

Integrum expands its product offering into the Israeli market

Cision Publicerad: 26 Mar 07:00

Mölndal, Sweden – March 26, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that the company has entered a commercial agreement with AMI Technologies, a leading local medical device distributor, to introduce the OPRA^TM Implant System in Israel.

As part of Integrum's efforts to expand the availability of the OPRA™ Implant System to new geographical markets, the company has as of today started a collaboration in Israel with AMI Technologies (www.ami.co.il).

“The collaboration with AMI Technologies secures a swift launch of OPRA™ Implant System in Israel and shortens the distance between us and patients needing reconstructive surgery. We see a large need for our innovative products in the region and hope we can help improve the quality of life for amputees,” says Rickard Brånemark, CEO of Integrum.

Bifogade filer

2024-03-26 PR Integrum Enters Israeli Markethttps://mb.cision.com/Public/17531/3952047/a8a6b8676b575e64.pdf

Nyheter om Integrum

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!